Stockscreener 앱 받기
1.58
6.51%
-0.11
전일 마감가:
$1.69
열려 있는:
$1.67
하루 거래량:
390.86K
Relative Volume:
1.36
시가총액:
$49.29M
수익:
$1.05M
순이익/손실:
$-48.82M
주가수익비율:
-0.8634
EPS:
-1.83
순현금흐름:
$-47.49M
1주 성능:
-11.24%
1개월 성능:
-2.47%
6개월 성능:
+37.39%
1년 성능:
-8.14%
1일 변동 폭
$1.52
$1.67
1주일 범위
$1.52
$1.78
52주 변동 폭
$1.06
$2.41
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
명칭
Actinium Pharmaceuticals Inc
전화
646-767-3870
주소
275 Madison Avenue, 7th Floor, New York, NY
ATNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.58 | 52.72M | 1.05M | -48.82M | -47.49M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-07 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-02-21 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-08-25 | 개시 | B. Riley Securities | Buy |
| 2020-11-05 | 개시 | Alliance Global Partners | Buy |
| 2017-12-06 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | 재개 | ROTH Capital | Buy |
| 2017-09-14 | 개시 | Maxim Group | Buy |
| 2016-08-25 | 개시 | ROTH Capital | Buy |
| 2016-02-29 | 개시 | H.C. Wainwright | Buy |
| 2015-10-15 | 개시 | FBR Capital | Outperform |
| 2014-10-01 | 개시 | MLV & Co | Buy |
| 2014-07-22 | 개시 | Canaccord Genuity | Buy |
모두보기
Actinium Pharmaceuticals Inc 주식(ATNM)의 최신 뉴스
key metrics from actinium pharmaceuticals inc.’s quarterly dataWeekly Market Summary & Weekly High Potential Stock Alerts - Newser
What machine learning models say about Actinium Pharmaceuticals Inc.Trade Exit Summary & Weekly Stock Breakout Alerts - Newser
What candlestick patterns are forming on Actinium Pharmaceuticals Inc.Price Action & Daily Stock Momentum Reports - Newser
Has Actinium Pharmaceuticals Inc. formed a bullish divergenceJuly 2025 Summary & Proven Capital Preservation Tips - Newser
Applying big data sentiment scoring on Actinium Pharmaceuticals Inc.2025 Macro Impact & Fast Entry Momentum Alerts - Newser
148,560 Shares in Actinium Pharmaceuticals, Inc. $ATNM Purchased by Nuveen LLC - Defense World
Is a relief rally coming for Actinium Pharmaceuticals Inc. holdersNew Guidance & Safe Entry Momentum Tips - Newser
Analyzing Actinium Pharmaceuticals Inc. with multi timeframe chartsJuly 2025 Reactions & Accurate Buy Signal Alerts - Newser
Key metrics from Actinium Pharmaceuticals Inc.’s quarterly data2025 Top Decliners & Intraday High Probability Alerts - Newser
Actinium Pharmaceuticals Inc. stock momentum explainedTrade Risk Report & Smart Swing Trading Techniques - Newser
Does Actinium Pharmaceuticals Inc. stock reflect fundamentals2025 Bull vs Bear & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Trend analysis for Actinium Pharmaceuticals Inc. this weekJuly 2025 Movers & Smart Allocation Stock Reports - Newser
Actinium Pharmaceuticals, Inc. $ATNM Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Intraday pattern recognizer results for Actinium Pharmaceuticals Inc.Weekly Trade Summary & Safe Entry Momentum Tips - Newser
Can Actinium Pharmaceuticals Inc. expand its profit marginsTrade Entry Summary & Advanced Technical Signal Analysis - خودرو بانک
Earnings Miss: Can Actinium Pharmaceuticals Inc. maintain its current growth rateJuly 2025 Volume & AI Enhanced Trading Alerts - خودرو بانک
What indicators show strength in Actinium Pharmaceuticals Inc.July 2025 Trade Ideas & Fast Moving Stock Trade Plans - Newser
Will Actinium Pharmaceuticals Inc. rebound enough to break evenWeekly Trend Summary & Fast Gaining Stock Strategy Reports - Newser
What to expect from Actinium Pharmaceuticals Inc. in the next 30 daysSwing Trade & AI Based Buy/Sell Signal Reports - Newser
What’s the outlook for Actinium Pharmaceuticals Inc.’s sectorJuly 2025 EndofMonth & Reliable Price Breakout Signals - خودرو بانک
How sentiment analysis helps forecast Actinium Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - Newser
Will Actinium Pharmaceuticals Inc. outperform during market ralliesJuly 2025 Patterns & Real-Time Buy Signal Alerts - خودرو بانک
Using fundamentals and technicals on Actinium Pharmaceuticals Inc.Trend Reversal & Risk Adjusted Buy/Sell Alerts - Newser
How to forecast Actinium Pharmaceuticals Inc. trends using time seriesTake Profit & Risk Controlled Daily Trade Plans - Newser
Will Actinium Pharmaceuticals Inc. see short term momentumWeekly Risk Report & Accurate Technical Buy Alerts - Newser
Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is Actinium Pharmaceuticals Inc. stock reversal real or fakeQuarterly Trade Summary & Free Safe Entry Trade Signal Reports - Newser
Should I average down on Actinium Pharmaceuticals Inc. stockJuly 2025 Momentum & Fast Moving Market Watchlists - خودرو بانک
Can Actinium Pharmaceuticals Inc. maintain its current growth rateJuly 2025 Technicals & Short-Term Swing Trade Alerts - خودرو بانک
Actinium Pharmaceuticals Inc. Crosses 200 Day MA — Signal or Noise getLinesFromResByArray error: size == 0 - 강소기업뉴스
Published on: 2025-09-01 15:24:32 - خودرو بانک
AI Trend Models Suggest Bounce for Actinium Pharmaceuticals Inc.Trade Risk Assessment & AI Driven Stock Price Forecasts - 선데이타임즈
What institutional flow reveals about Actinium Pharmaceuticals Inc.Weekly Trade Review & High Conviction Buy Zone Alerts - Newser
Is Actinium Pharmaceuticals Inc. meeting your algorithmic filter criteriaMarket Trend Review & Reliable Entry Point Alerts - Newser
Visualizing Actinium Pharmaceuticals Inc. stock with heatmapsPrice Action & Fast Gaining Stock Reports - Newser
Actinium Pharmaceuticals Inc (ATNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):